Cited by 1,458Long-Term Effects of COVID-19Olfactory and Sensory Function StudiesSARS-CoV-2 and COVID-19 Research

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Open access
Meinhardt, Jenny, Radke, Josefine, Dittmayer, Carsten, Franz, Jonas, Thomas, Carolina, Mothes, Ronja, Laue, Michael, Schneider, Julia +35 more·2021·Nature Neuroscience

Published version of a preprint

Abstract

The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease. Moreover, thromboembolic events throughout the body, including in the CNS, have been described. Given the neurological symptoms observed in a large majority of individuals with COVID-19, SARS-CoV-2 penetrance of the CNS is likely. By various means, we demonstrate the presence of SARS-CoV-2 RNA and protein in anatomically distinct regions of the nasopharynx and brain. Furthermore, we describe the morphological changes associated with infection such as thromboembolic ischemic infarction of the CNS and present evidence of SARS-CoV-2 neurotropism. SARS-CoV-2 can enter the nervous system by crossing the neural–mucosal interface in olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue, including delicate olfactory and sensory nerve endings. Subsequently, SARS-CoV-2 appears to follow neuroanatomical structures, penetrating defined neuroanatomical areas including the primary respiratory and cardiovascular control center in the medulla oblongata. The authors demonstrate the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting that the virus is present in the CNS and may enter through the olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41593-020-00758-5

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SARS-CoV-2 invades the brain through the olfactory route and the vagus nerve, which may cause early olfactory loss, gastrointestinal and respiratory dysfunctions in COVID-19 patients.

    “The neuroinvasive nature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) allows it to invade the brain through both the olfactory route and the vagus nerve, which may be an important mechanism for causing clinical symptoms such as early olfactory loss, gastrointestinal and respiratory dysfunctions in COVID-19 patients.270,271”
  • Autopsy evidence from COVID-19 patients demonstrates that SARS-CoV-2 enters the central nervous system partly through the olfactory mucosal-nervous milieu, supported by high viral RNA levels in the olfactory mucosa and presence of SARS-CoV spike protein in olfactory neurons.

    “Autopsy evidences from COVID-19 patients directly demonstrated that SARS-CoV-2 enters the CNS partly through the olfactory mucosal-nervous milieu. This is supported by high viral RNA levels in the olfactory mucosa, and the presence of SARS-CoV spike protein in olfactory neurons.271”
  • Some control samples without viral infection had high cycle counts between 37 and 40, which previous work without such controls interpreted as evidence of neuroinvasion.

    “Some of the samples from the control individuals without viral infection have high cycle counts (between 37 and 40), which in previous work (without such controls) has been interpreted as evidence of neuroinvasion9,18.”
  • A recent study pointed to the neural-mucosa interface in olfactory mucosa as a potential port of CNS entry for SARS-CoV-2.

    “A recent study pointed out to the neural–mucosa interface in olfactory mucosa as a potential port of CNS entry for SARS-CoV-2 [167].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., Lehmann, M., Hassan, O., Aschman, T., Schumann, E., Chua, R. L., Conrad, C., Eils, R., Stenzel, W., Windgassen, M., Rößler, L., Goebel, H.-H., Gelderblom, H. R., Martin, H., Nitsche, A., Schulz-Schaeffer, W. J., Hakroush, S., Winkler, M. S., Tampe, B., Scheibe, F., Körtvélyessy, P., Reinhold, D., Siegmund, B., Kühl, A. A., Elezkurtaj, S., Horst, D., Oesterhelweg, L., Tsokos, M., Ingold-Heppner, B., Stadelmann, C., Drosten, C., Corman, V. M., Radbruch, H., & Heppner, F. L.
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • Universitätsmedizin Göttingen (DE)
  • Robert Koch Institute (DE)
  • Heidelberg University (DE)
  • Otto-von-Guericke-Universität Magdeburg (DE)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Heppner, Frank L.
Venue
Nature Neuroscience
Published
2020-11-30
Volume
24
Issue
2
Pages
168-175
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W3106791064
Cited by
1,458
References
51
Citations by year
2026: 56 · 2025: 108 · 2024: 194 · 2023: 249 · 2022: 411 · 2021: 408 · 2020: 30
FWCI
119.76
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion, other-oa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, other-oa)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, other-oa)
  • DZNE Pub (submittedVersion)
  • Robert-Koch-Institut (RKI)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
SARS-CoV-2, COVID-19 pandemic, olfactory epithelium, neurotropism, medulla oblongata, nasopharynx, neurological symptoms, olfactory nerve
MeSH terms
COVID-19, SARS-CoV-2, Brain, Central Nervous System, Humans, Olfactory Mucosa, RNA, Viral, Smell, Virus Internalization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review